Eagle Bay Advisors LLC Roivant Sciences Ltd. Transaction History
Eagle Bay Advisors LLC
- $163 Million
- Q2 2024
A detailed history of Eagle Bay Advisors LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 506 shares of ROIV stock, worth $6,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
506
Previous 506
-0.0%
Holding current value
$6,072
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$856 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$830 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$801 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$424 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$352 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.45B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...